Human cancer cell lines- A brief communication

Journal of Chemical and Pharmaceutical Research

Volumn 3, Issue 6, 2011, Pages 514-520

  Kashyap, C P ^a   Tikka, Bandana ^a   Sharma, Shikha ^a   Kumari, Sweta ^a   Verma, Priti ^a   Sharma, Swati ^a   Arya, Vikrant ^a  

^a College of Ayurvedic Pharmaceutical Sciences ^*  (India)

Author keywords

Cancer; Cell line; Tumour

Indexed keywords

CANCER; CELL LINES; COLORECTAL ADENOCARCINOMA; HUMAN CANCER CELLS; ORAL SQUAMOUS CELL CARCINOMATA; PANCREATIC ADENOCARCINOMA; PROMYELOCYTIC LEUKEMIA; SKIN FIBROBLAST CELLS;

CELL CULTURE; CELLS; COMMUNICATION; ONCOLOGY; TUMORS;

DISEASES;

ETODOLAC; FLUOROURACIL; MICRORNA 126; SURVIVIN; TAMOXIFEN; VASCULOTROPIN A;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER SCREENING; CARCINOMA; CELL ASSAY; CELL PROLIFERATION; CLONOGENIC ASSAY; CYTOTOXICITY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE MUTATION; GYNECOLOGIC CANCER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LARYNX CANCER; LIVER CANCER; LUNG CANCER; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; OVARY CANCER; PROSTATE CANCER; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SALIVARY GLAND CANCER; STOMACH CANCER; TUMOR XENOGRAFT;

EID: 84863110202     PISSN: None     EISSN: 09757384     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. JE Green. Breast Cancer Res., 2003, 5(1), 1.
2. N White. Phil.Trans. R. Soc. Lond. B. 1999, 354, 739-749.
3. Y Hathout. Expert Rev Proteomics 2007, 4, 239-48.
4. RM Neve et al. Cancer cell 2006, 10, 515-527.
5. E Boven et al. Int. J. Cancer 1997, 70, 335-340.
6. N Ozturk et al. PNAS 2006, 103, 2178-2183.
7. A Ghosh; WD Heston. J Cell Biochem 2004, 91, 528-39.
8. BS Taylor et al. Mol Cell Proteomics 2008, 7, 600-11.
9. PI Karakiewicz; GC Hutterer. Nat Clin Pract Urol 2008, 5, 82-92.
10. SF Shariat et al. J Clin Oncol 2008, 26, 1526-31.
11. J Viallet; MS Tsao; G. Gallant. Lung cancer 1996, 93-101.
12. XH Liu; JM Connoly; DP Rose. Cancer letters 1996, 223-230.
13. Y Li et al. Cancer letters 2004, 205, 161-171.
14. D Dhawan et al. Urologic Oncology 2009, 27, 284-292.
15. SC Dixon et al. Cancer Letters 1997, 113, 111-116.
16. V Csernus; AV Schally; K Groot. Peptides 1999, 20, 843-850.
17. U Valentiner et al. Toxicology 2002, 171, 187-199.
18. Z Wen-Yun et al. Chinese Journal of Biotechnology, 2006, 22(2), 285-292.
19. M Miyazawa et al. Cancer Letters 2011, 305, 32-39.
20. JW Liu et al. Journal of Ethnopharmacology 2007, 113, 115-124.
21. E Kobayashi et al. Cancer Letters 1999, 140, 139-143.
22. S. Marchini et al. European Journal of Cancer 2005, 41, 323-333.
23. YW Qin et al. Lung Cancer 2009, 66, 169-175.
24. GA Turner et al. Cancer Letters 1995, 91, 229-234.
25. M Sato et al. Cancer Letters 1997, 115, 149-160.
26. SK Singh et al. Chemico-Biological Interactions 2008, 171, 45-56.
27. HH Chen; HJ Zhou; X Fang. Pharmacological Research 2003, 48, 231-236.
28. K Shigemura et al. Urology 2005, 66 (6), 1240-1244.
29. R Prasanna et al. Cell Biology International 2009, 33, 127-134.
30. V Rantanen et al. European Journal of Cancer 2002, 38, 1783-1791.
31. A Otsubo et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 103, 391-7.
32. M Bologna et al. Urology 1995, 45(2), 282-290.
33. O Treeck et al. Cytokine 2005, 32, 137-142.
34. R Iwazaki et al. Cancer Letters 1997, 119, 191-199.
35. S Matsumoto et al. Lung Cancer 2005, 47, 31-39.
36. R Jayakumar et al. Carbohydrate Polymers 2011, 84, 407-416.
37. K Polkowski et al. Cancer Letters 2004, 203, 59-69.
38. Y Kawakami et al. European Journal of Cancer 2000, 36, 1991-1997.
39. H Yano et al. Journal of Hepatology 2004, 41, 782-789.
40. JH Kessler et al. Cancer Letters 2007, 251, 132-145.
41. JE Dumont et al. Biochimica et Biophysica Acta 2009, 1795, 92-103.
42. KS Rangappa et al. European Journal of Medicinal Chemistry 2009, 44, 1223-1229.
43. J Zhou et al. Current therapeutic research 2010, 71(4), 239-251.
44. M Akutsu et al. European Journal of Cancer 1995, 31A (13-14), 2341-2346.
45. JP Brussel et al. Eur J Cancer 1999, 35(4), 664-671.
46. MR Zalutsky et al. Nuclear Medicine and Biology 2006, 33, 333-347.
47. JS Oliveira et al. Toxicology in Vitro 2007, 21, 1563-1573.
48. E Kobayash et al. Cancer Letters 1999, 140, 139-143.